898 abstracts found.



Results filter

Audit of rate of BRCA1/2 detection when all patients with papillary serous ovarian cancer are tested,regardless of family history or manchester score

Year:

Session type:

Elspeth Murray1, Michelle Ferguson2,
1University of Dundee, Dundee, UK,2NHS Tayside, Dundee, UK

Early Stage Endometrial Cancer treated with surgery and no adjuvant treatment – To Follow-up or Not?

Year:

Session type:

Moray Kyle1, Alison Stillie1,
1Edinburgh Cancer Centre, Edinburgh, UK

Sterilization and ovarian cancer in the Million Women Study: variation by histological subtype

Year:

Session type:

Kezia Gaitskell1, Jane Green1, Kirstin Pirie1, Gillian Reeves1, Valerie Beral1,
1Cancer Epidemiology Unit, University of Oxford, Oxford, UK

Regulation of cell cycle by the epigenetic modifiers KMT2C and KMT2D and their therapeutic potential in Pancreatic Ductal Adenocarcinoma (PDAC)

Year:

Session type:

Joshua Dawkins1, Eleni Maniati1, Thorsten Hagemann1,
1Barts Cancer Institute, London, UK

Insulin-like growth factor-I and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition

Year:

Session type:

Julie A Schmidt1, Ruth C Travis1,
1Cancer Epidemiology Unit, University of Oxford, Oxford, UK

DNA-PK as a biomarker of non-homologous end joining in ovarian cancer

Year:

Session type:

Richard O'Sullivan1, Peter Donoghue1, Nicola Curtin1, Angelika Kaufmann1, Aiste McCormick1, Richard Edmondson2,
1Northern Institute for Cancer Research, Newcastle University, Newcastle, UK,2Institute for Cancer Sciences, Manchester University, Manchester, UK

Body fat percentage, physical activity and breast cancer risk in 126,000 postmenopausal women in UK Biobank

Year:

Session type:

Wenji Guo1, Tim Key1,
1University of Oxford, Oxford, UK

Early outcomes with ipilimumab for metastatic melanoma: a single institution retrospective analysis

Year:

Session type:

Alexandra Teagle1, Duncan Gilbert1, Sarah Westwell1,
1Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK

Children diagnosed with solid tumors, 1990-2013: a single institution study of medical radiation exposure

Year:

Session type:

Robin Rohrer1,
1Seton Hill University, Greensburg, Pennsylvania, USA

MEK inhibition enhances gemcitabine efficacy by increasing MDM2-mediated ubiquitination and degradation of RRM1

Year:

Session type:

Francesca Vena1, Eleonora Li Causi2, John A. Hartley1, Thorsten Hagemann2, Samantha Goodstall3, Daniel Hochhauser1,
1UCL cancer institute, London, UK,2Barts Cancer institute, London, UK,3EMD Serono, Billerica, MA, USA

Page 25 of 90« First...25...50...Last »